LUNAC Therapeutics Overview
- Founded
- 2018
- Status
- Private
- Latest Deal Type
- Grant
- Latest Deal Amount
- $4.05M
- Investors
- 3
LUNAC Therapeutics General Information
Description
Developer of advanced oral anticoagulant designed to treat and prevent life-threatening thrombotic events. The company's advanced oral anticoagulant minimizes the bleeding risk, enabling healthcare providers to handle high-risk patients with safe dose escalation.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- Secretariat, Ec Stoner Building
- Woodhouse Lane
- Leeds LS2 9JT
- England, United Kingdom
LUNAC Therapeutics Timeline
LUNAC Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 02-Dec-2019 | $4.05M | 00.00 | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 14-Nov-2019 | 00.00 | 00.00 | 00.000 | Completed | Generating Revenue |
LUNAC Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 000,000 | 00.000000 | 00 | 000.00 | 000.00 | 00 | 000.00 | 00.00 |
LUNAC Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Helen Philippou | Scientific Co-Founder & Board Member | ||
| Richard Foster | Scientific Co-Founder |
LUNAC Therapeutics Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Helen Philippou | LUNAC Therapeutics | Scientific Co-Founder & Board Member | 000 0000 |
| Mary Canning Ph.D | Epidarex Capital | Board Member | 000 0000 |
| Mervyn Turner Ph.D | Self | Chairman | 000 0000 |
| Peter Finan Ph.D | Epidarex Capital | Board Member | 000 0000 |
| Sarah Jarmin | Self | Board Member | 000 0000 |
LUNAC Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| UK Government's Biomedical Catalyst funding | Government | 000 0000 | 000000 0 | ||
| Epidarex Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| University of Leeds Endowment | Limited Partner | Minority | 000 0000 | 000000 0 |